Tools

Wilkie, M and Davies, S (2018) Does alanyl-glutamine supplementation offer potential to improve peritoneal dialysate biocompatibility? Kidney International, 94 (6). 1050 -1052. ISSN 1523-1755

[thumbnail of KI-09-18-1286.pdf]
Preview
 Text
KI-09-18-1286.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (248kB) | Preview

Abstract

Peritoneal dialysis technique survival remains challenging due to peritonitis and long-term alterations to peritoneal membrane function and integrity. Up to now, the development of less bio-incompatible dialysis solutions have not had a major impact on these aspects of the therapy. A novel approach, supplementing dialysis solutions with a cytoprotective additive, alanyl-glutamine, has shown benefits to surrogate biomarkers of cell function in a randomized controlled study.

Item Type: Article
Additional Information: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Elsevier at http://doi.org.10.1016/j.kint.2018.09.012 - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: peritonitis, peritoneal dialysis, dialysis
Subjects: R Medicine > RC Internal medicine > RC902 Nephrology
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 04 Feb 2019 09:10
Last Modified: 19 Nov 2019 01:30
URI: https://eprints.keele.ac.uk/id/eprint/5747

Actions (login required)

View Item
View Item
Altmetric